NDC 63323-751-00 - Phenylephrine Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63323-751
- Requested NDC
- 63323-751-00
- Package NDCs from labels
- 63323-751-05, 63323-751-10, 63323-751-00, 63323-751-01, 63323-751-03, 63323-751-13
- Manufacturer
- Fresenius Kabi USA, LLC
- Effective date
- 2026-10-20
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Phenylephrine Hydrochloride - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2026-10-20 | HUMAN PRESCRIPTION DRUG LABEL |
| Phenylephrine Hydrochloride - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2025-05-15 | HUMAN PRESCRIPTION DRUG LABEL |
| PHENYLEPHRINE HYDROCHLORIDE - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2024-02-22 | HUMAN PRESCRIPTION DRUG LABEL |
| Phenylephrine Hydrochloride - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2023-12-11 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63323-751-00 | Phenylephrine Hydrochloride | 1 mL in 1 VIAL, SINGLE-DOSE | INJECTION | 1 | 8 | |
| 63323-751-01 | Phenylephrine Hydrochloride | 25 in 1 CARTON | INJECTION | 25 | 8 | |
| 63323-751-05 | Phenylephrine Hydrochloride | 5 mL in 1 VIAL, PHARMACY BULK PACKAGE | INJECTION | 5 | 4 | |
| 63323-751-05 | Phenylephrine Hydrochloride | 1 in 1 CARTON | INJECTION | 1 | 4 | |
| 63323-751-10 | Phenylephrine Hydrochloride | 10 mL in 1 VIAL, PHARMACY BULK PACKAGE | INJECTION | 10 | 4 | |
| 63323-751-10 | Phenylephrine Hydrochloride | 1 in 1 CARTON | INJECTION | 1 | 4 | |
| 63323-751-03 | Phenylephrine Hydrochloride | 1 mL in 1 VIAL, SINGLE-DOSE | INJECTION | 1 | 2 | |
| 63323-751-13 | Phenylephrine Hydrochloride | 25 in 1 CARTON | INJECTION | 25 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63323-751 | PHENYLEPHRINE HYDROCHLORIDE (PHENYLEPHRINE HYDROCHLORIDE) INJECTION [FRESENIUS KABI USA, LLC ] | 7 | Current NDC, Legacy NDC, 2 package rows | 20231208_1e77b9c8-fa17-4aa4-adc8-ff716ab2e5d7.zip |
| 63323-751 | PHENYLEPHRINE HYDROCHLORIDE (PHENYLEPHRINE HYDROCHLORIDE) INJECTION [FRESENIUS KABI USA, LLC ] | 4 | Current NDC, Legacy NDC, 4 package rows | 20240125_c7026b15-1228-4acb-beed-4474fcdbb972.zip |
| 63323-751 | PHENYLEPHRINE HYDROCHLORIDE (PHENYLEPHRINE HYDROCHLORIDE) INJECTION [FRESENIUS KABI USA, LLC ] | 2 | Current NDC, Legacy NDC, 2 package rows | 20240110_f2dce7f1-6538-4747-9792-665eee45c0a9.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63323-751-00 | ML - Milliliter | 63323-751 | 1394c34e-4c42-4094-b1b2-afcdc13e132b | 1 | 2019-07-02 |
| 63323-751-01 | ML - Milliliter | 63323-751 | a8b40ddc-6423-477a-9e40-f4a05b934ade | 1 | 2019-07-02 |
| 63323-751-03 | ML - Milliliter | 63323-751 | cf951bf5-4a25-4cb0-9c6b-c9e4c8cb2180 | 1 | 2020-08-06 |
| 63323-751-05 | ML - Milliliter | 63323-751 | 321cea9d-af97-405d-9cb3-812f3c5e23d3 | 1 | 2019-07-02 |
| 63323-751-10 | ML - Milliliter | 63323-751 | 9610d875-e8cc-4c7b-83b7-8b4ebf6a4e9e | 1 | 2019-07-02 |
| 63323-751-13 | ML - Milliliter | 63323-751 | ec8453b5-99f8-4776-90d2-3d17719905cf | 1 | 2020-08-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Hemorrhoidal Cream | GLYCEROL, PHENYLEPHINE, PRAMOXINE, PETROLATUM | Trifecta Pharmaceuticals Usa Llc | 38cf4e43-280b-eb96-e063-6294a90a5949 | 2025-07-02 | Warnings | 04JA59TNSJ |
| DIANEAL LOW CALCIUM WITH DEXTROSE | SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE AND DEXTROSE | Vantive US Healthcare LLC | 0956bd7c-d46f-483a-bf2c-9e11c6111ebf | 2025-07-02 | 451W47IQ8X | |
| DIANEAL LOW CALCIUM WITH DEXTROSE | SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE AND DEXTROSE | Vantive US Healthcare LLC | b79ef556-37b3-4fd0-8589-c633033be9df | 2025-07-02 | 451W47IQ8X | |
| Parasode | ARTEMISIA VULGARIS ROOT, CHELIDONIUM MAJUS WHOLE, PUNICA GRANATUM ROOT BARK, SPIGELIA ANTHELMIA WHOLE, KRAMERIA LAPPACEA ROOT, ARSENIC TRIOXIDE, IRON, OYSTER SHELL CALCIUM CARBONATE, CRUDE, ARTEMISIA CINA PRE-FLOWERING TOP, SALMONELLA ENTERICA ENTERICA SEROVAR ENTERITIDIS, GRAPHITE, CALOMEL, SODIUM CHLORIDE, AND SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE | Zorex | 0ed722dc-cd25-4a15-b3f8-052cc7bcd9ec | 2025-07-01 | Warnings | 451W47IQ8X |
| EXTRANEAL | ICODEXTRIN, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE | Vantive US Healthcare LLC | d5b85158-b0d6-4855-9d07-8d1b3ad9ab71 | 2025-06-30 | Warnings, Adverse reactions | 451W47IQ8X |
| SODIUM CHLORIDE | SODIUM CHLORIDE | Baxter Healthcare Corporation | 958d35f0-6834-43be-a700-fa58f38b4c19 | 2025-06-30 | Warnings, Adverse reactions | 451W47IQ8X |
| InterSol | PLATELET ADDITIVE 3 | Fenwal, Inc. | 17dec820-1b57-4ac9-82a8-419cab664a2f | 2025-06-27 | Warnings, Adverse reactions | 451W47IQ8X B22547B95K |
| Nauzene Chewables Ginger Honey | SODIUM CITRATE | Kobayashi Healthcare International, Inc. | 25c9825d-a4e8-4671-e063-6294a90ab46d | 2025-06-24 | Warnings | B22547B95K |
| Phenylephrine Hemorrhoidal | HEMORRHOIDAL SUPPOSITORIES | Neilmed Pharmaceuticals Inc. | 35ccb320-e902-3d1a-e063-6294a90a68d5 | 2025-06-20 | Warnings | 04JA59TNSJ |
| TYLENOL Cold Plus Flu Severe | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | Morning Star OTC | be95332d-a2e0-42e8-bfb3-8850d74990ff | 2025-06-19 | Warnings | 04JA59TNSJ |
| Tylenol Sinus Severe | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | Morning Star OTC | 37e939c6-064b-3548-e063-6294a90a337d | 2025-06-19 | Warnings | 04JA59TNSJ |
| ProCure Hemorrhoidal | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCL | Twin Med LLC | 37a4cc43-0d53-f1bf-e063-6394a90a2dc9 | 2025-06-15 | Warnings | 04JA59TNSJ |
| Hemorrhoidal Pain Relief | HEMORRHOIDAL PAIN RELIEF OINTMENT | Neilmed Pharmaceuticals Inc. | 374d89b6-9305-9adf-e063-6394a90adb32 | 2025-06-11 | Warnings | 04JA59TNSJ |
| foster and thrive hemorrhoidal | COCOA BUTTER, PHENYLEPHRINE HCL | Strategic Sourcing Services LLC | fb3bc359-b06b-4995-aa68-0117a639dff2 | 2025-06-11 | Warnings | 04JA59TNSJ |
| Cold Max Nighttime | ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, AND PHENYLEPHRINE HYDROCHLORIDE | RETAIL BUSINESS SERVICES , LLC. | e65d2815-6932-123c-e053-2a95a90a2cf9 | 2025-06-10 | Warnings | 04JA59TNSJ |
| Cold Head Congestion Daytime | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND PHENYLEPHRINE HYDROCHLORIDE | American Sales Company | 0cc66c6c-db26-4bb2-a97d-c4106210d70c | 2025-06-10 | Warnings | 04JA59TNSJ |
| HemorrhoidalOintment | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCI | Trifecta Pharmaceuticals USA LLC | 4eb3c9ac-268a-5246-e054-00144ff88e88 | 2025-06-09 | Warnings | 04JA59TNSJ |
| Nuvicare DayTime Cold and Flu Softgel | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE | NUVICARE LLC | bdc35570-c8df-4797-a13e-7f2479ec42b7 | 2025-06-09 | Warnings | 04JA59TNSJ |
| HAIR STIM | PEDICULUS CAPITIS, THYROIDINUM (SUIS), BARYTA CARBONICA, BORAX, CALCAREA CARBONICA, CINCHONA OFFICINALIS, GLANDULA SUPRARENALIS SUIS, HYDROFLUORICUM ACIDUM, MERCURIUS SOLUBILIS, MEZEREUM, NATRUM MURIATICUM, PHOSPHORUS, PULSATILLA (PRATENSIS), SEPIA, SILICEA, SULPHUR, THUJA OCCIDENTALIS, VINCA MINOR | The Wellness Center for Research and Education, Inc. | 8ecc05ff-ed5a-4157-9100-1c7912686f07 | 2025-06-06 | Warnings | 451W47IQ8X |
| Hemorrohoid Master Cream | LIDOCAINE, PHENYLEPHRINE HCL | Ebanel Laboratories, Inc. | 36eccc74-107e-3914-e063-6294a90a1856 | 2025-06-06 | Warnings | 04JA59TNSJ |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.